Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA
  • Print
  • Share
  • E-mail
-

FDA-TRACK Home Page or Advisory Committees Index

Percent of FDA advisory committee member positions vacant at the end of the month

Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm

Information is current as December 31, 2020.

Fiscal Year - 2021

Skip graphic and jump to text data

TimeTargetPercent Vacant Positions
Oct 20201016
Nov 20201018
Dec 20201017
Jan 202110TBD
Feb 202110TBD
Mar 202110TBD
Apr 202110TBD
May 202110TBD
Jun 202110TBD
Jul 202110TBD
Aug 202110TBD
Sep 202110TBD

FY 2021 YTD: 16%

Number of FDA advisory committee member positions vacant at the end of the month

Fiscal Year - 2021
Skip graphic and jump to text data.

TimeTargetVacant Positions
Oct 2020N/A88
Nov 2020N/A98
Dec 2020N/A89
Jan 2021N/ATBD
Feb 2021N/ATBD
Mar 2021N/ATBD
Apr 2021N/ATBD
May 2021N/ATBD
Jun 2021N/ATBD
Jul 2021N/ATBD
Aug 2021N/ATBD
Sep 2021N/ATBD

FY 2021 YTD: 89

Total number of FDA advisory committee member positions at the end of the month

Fiscal Year - 2021
Skip graphic and jump to text data.

TimeTargetPositions
Oct 2020N/A547
Nov 2020N/A547
Dec 2020N/A547
Jan 2021N/ATBD
Feb 2021N/ATBD
Mar 2021N/ATBD
Apr 2021N/ATBD
May 2021N/ATBD
Jun 2021N/ATBD
Jul 2021N/ATBD
Aug 2021N/ATBD
Sep 2021N/ATBD

FY 2021 YTD: 547

Footnotes

  • CVM's Advisory Committee was terminated on September 30, 2013.

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
-
-